Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 247

1.

Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita.

Iwata H, Witte M, Samavedam UK, Gupta Y, Shimizu A, Ishiko A, Schröder T, Seeger K, Dahlke M, Rades D, Zillikens D, Ludwig RJ.

J Immunol. 2015 Jul 22. pii: 1501003. [Epub ahead of print]

PMID:
26202985
2.

Nipple-sparing mastectomy in breast cancer patients: The role of adjuvant radiotherapy (Review).

Janssen S, Holz-Sapra E, Rades D, Moser A, Studer G.

Oncol Lett. 2015 Jun;9(6):2435-2441. Epub 2015 Mar 27.

3.

Estimation of the Six-month Survival Probability After Radiosurgery for Brain Metastases from Kidney Cancer.

Janssen S, Dahlke M, Trang NT, Khoa MT, Rades D.

Anticancer Res. 2015 Jul;35(7):4215-7.

PMID:
26124381
4.
5.

Predicting Survival After Irradiation of Metastases from Pancreatic Cancer.

Bolm L, Janssen S, Käsmann L, Wellner U, Bartscht T, Schild SE, Rades D.

Anticancer Res. 2015 Jul;35(7):4105-8.

PMID:
26124362
6.

Impact of stereotactic radiosurgery dose on control of cerebral metastases from renal cell carcinoma.

Rades D, Huttenlocher S, Gebauer N, Hornung D, Trang NT, Khoa MT, Schild SE.

Anticancer Res. 2015 Jun;35(6):3571-4.

PMID:
26026128
7.

Favorable prognostic impact of RAS mutation status in multiple myeloma treated with high-dose melphalan and autologous stem cell support in the era of novel agents: a single center perspective.

Gebauer N, Biersack H, Czerwinska AC, Schemme J, Hardel TT, Bernard V, Rades D, Lehnert H, Luley KB, Thorns C.

Leuk Lymphoma. 2015 Jun 18:1-4. [Epub ahead of print] No abstract available.

PMID:
25947035
8.

A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses.

Rades D, Huttenlocher S, Veninga T, Bajrovic A, Bremer M, Rudat V, Schild SE.

Radiat Oncol. 2015 Apr 15;10(1):90. doi: 10.1186/s13014-015-0403-y.

9.

Nuclear expression of p65 (RelA) in patients receiving post-operative radiotherapy for locally advanced squamous cell carcinoma of the head and neck.

Rades D, Huttenlocher S, Seibold ND, Gebhard MP, Thorns C, Hasselbacher K, Wollenberg B, Schild SE.

BMC Cancer. 2015 Mar 6;15:102. doi: 10.1186/s12885-015-1107-2.

10.

A new tool to predict survival after radiosurgery alone for newly diagnosed cerebral metastases.

Rades D, Huttenlocher S, Dziggel L, Blanck O, Hornung D, Mai KT, Ngo TT, Van Pham T, Schild S.

Asian Pac J Cancer Prev. 2015;16(7):2967-70.

11.

A new instrument for estimating the survival of patients with metastatic epidural spinal cord compression from esophageal cancer.

Rades D, Huttenlocher S, Bajrovic A, Karstens JH, Bartscht T.

Radiol Oncol. 2015 Mar 3;49(1):86-90. doi: 10.2478/raon-2014-0043. eCollection 2015 Mar.

12.

Pulmonary vein isolation by radiosurgery: implications for non-invasive treatment of atrial fibrillation.

Bode F, Blanck O, Gebhard M, Hunold P, Grossherr M, Brandt S, Vonthein R, Thiele H, Dunst J, Rades D.

Europace. 2015 Mar 3. pii: euu406. [Epub ahead of print]

PMID:
25736725
13.

Predicting the survival probability of gastric cancer patients developing metastatic epidural spinal cord compression (MESCC).

Rades D, Huttenlocher S, Bartscht T, Schild SE.

Gastric Cancer. 2015 Jan 15. [Epub ahead of print]

PMID:
25588752
14.

Predicting survival of patients with metastatic epidural spinal cord compression from cancer of the head-and-neck.

Rades D, Schild SE, Karstens JH, Hakim SG.

Anticancer Res. 2015 Jan;35(1):385-8.

PMID:
25550576
15.

Radiosurgery with 20 Gy provides better local contol of 1-3 brain metastases from breast cancer than with lower doses.

Rades D, Huttenlocher S, Rudat V, Hornung D, Blanck O, Phuong PC, Khoa MT, Schild SE, Fischer D.

Anticancer Res. 2015 Jan;35(1):333-6.

PMID:
25550568
16.

A new tool predicting survival after radiosurgery alone for one or two cerebral metastases from lung cancer.

Rades D, Huttenlocher S, Dziggel L, Khoa MT, Van Thai P, Hornung D, Schild SE.

Lung. 2015 Apr;193(2):299-302. doi: 10.1007/s00408-014-9676-4. Epub 2014 Dec 21.

PMID:
25528743
17.

Genomic landscape of pancreatic neuroendocrine tumors.

Gebauer N, Schmidt-Werthern C, Bernard V, Feller AC, Keck T, Begum N, Rades D, Lehnert H, Brabant G, Thorns C.

World J Gastroenterol. 2014 Dec 14;20(46):17498-506. doi: 10.3748/wjg.v20.i46.17498.

18.

Comparison of two dose levels of stereotactic radiosurgery for 1-3 brain metastases from non-small cell lung cancer.

Rades D, Huttenlocher S, Dahlke M, Hornung D, Blanck O, Van Thai P, Trang NT, Khoa MT, Schild SE.

Anticancer Res. 2014 Dec;34(12):7309-13.

PMID:
25503165
19.

Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer.

Rades D, Huttenlocher S, Hornung D, Blanck O, Schild SE.

BMC Cancer. 2014 Dec 11;14:931. doi: 10.1186/1471-2407-14-931.

20.

Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery?

Rades D, Huttenlocher S, Hornung D, Blanck O, Schild SE, Fischer D.

Radiat Oncol. 2014 Dec 4;9:267. doi: 10.1186/s13014-014-0267-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk